Rigel Pharmaceuticals
Price & Volume
Stats
See moreOpen | $26 |
Previous Close | $26.37 |
Day Range | $25.82-$26.48 |
52W Range | $15.50-$52.24 |
Market Cap | $487.1M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $294.2M |
Revenue Growth (YoY) | 21.2% |
Gross Profit (12 Mos) | $241.3M |
Diluted EPS | $19.48 |
News
See moreYahoo Finance • 11 days ago
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data
Yahoo Finance • 25 days ago
Rigel Pharmaceuticals GAAP EPS of $13.54 beats by $12.31, revenue of $69.8M beats by $1.1M
Yahoo Finance • 25 days ago
Rigel Pharmaceuticals Q4 2025 Earnings Preview
Yahoo Finance • 4 months ago
Rigel's R289 Shows Promising RBC Transfusion Independence In Phase 1b Trial In Lower-Risk MDS
About
CEO | Mr. Raul R. Rodriguez |
CFO | Mr. Dean L. Schorno CPA |
Address | 611 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 172 |
